Remove 2022 Remove Clinical Pharmacology Remove Vaccines
article thumbnail

Lipid Nanoparticles Immunogenicity & Toxicity | December 6-8, 2022

pharmaphorum

Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response. . Download the full event guide to find out more.

article thumbnail

FDA Advisory Committee Review of 2021

Eye on FDA

FDA has scheduled the first advisory committee meetings of 2022. But before heading into 2022, it is perhaps time to take stock of AdComms and what they did or did not do during 2021. Fewer Meetings. First and foremost is that as noted earlier this year (See August 5, 2021 FDA Adcomms – Is FDA Getting Less Advice?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

Designation: Chief Commercial Officer (CCO) and President Award & Nominations: She has her mention in Fortune’s “Top 50 Most Powerful Women” in 2020, 2021, and 2022 ranking 16th, 11th, and 13th respectively. Hatfield Economic Fellow at Cornell University in 2022. She was also selected as the 39th Robert S.

article thumbnail

2022 in review: Drug development milestones for tropical diseases

Pharmaceutical Technology

Pharmaceutical Technology lists some of the top events in the tropical disease arena in 2022. Novel therapeutics and vaccines for malaria. As per the WHO’s 2022 malaria report , 63,000 malaria deaths were attributed to Covid-19-caused disruptions to services from 2019–21.